Evidence map›Paper›PMID 41006271›Full record

ReviewNature communications2025

Advances in biomonitoring technologies for women's health.

Shaghayegh Moghimikandelousi, Lubna Najm, Yerim Lee, Fereshteh Bayat, Akansha Prasad, Shadman Khan, Aishwarya Bhavan, Wei Gao, Zeinab Hosseinidoust, Tohid F Didar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shaghayegh Moghimikandelousi *School of Biomedical Engineering, McMaster University, Hamilton, ON, Canada.
Lubna Najm *Department of Mechanical Engineering, McMaster University, Hamilton, ON, Canada.
Yerim Lee *Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0009-0008-6774-1125
Fereshteh BayatDepartment of Mechanical Engineering, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0002-8868-1650
Akansha PrasadSchool of Biomedical Engineering, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0002-2636-5097
Shadman KhanAndrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA.
Aishwarya BhavanDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Wei GaoAndrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA. weigao@caltech.edu.ORCID http://orcid.org/0000-0002-8503-4562
Zeinab HosseinidoustSchool of Biomedical Engineering, McMaster University, Hamilton, ON, Canada. doust@mcmaster.ca.
Tohid F DidarSchool of Biomedical Engineering, McMaster University, Hamilton, ON, Canada. didart@mcmaster.ca.ORCID http://orcid.org/0000-0002-8757-8002

Funding

U.S. Department of Health & Human Services | National Institutes of Health (NIH) ARPA-H-ICHUB-24-101-504
6 · The paper itself

Abstract

In global healthcare systems, sex and gender biases have favored cisgender males, which has led women and transgender individuals to be understudied and underrepresented in medical literature. Thus, these populations are largely overlooked in health policy making. Persistent gender inequalities, socioeconomic divides, and racial-ethnic discrimination, particularly in low-resource communities, have exacerbated women's health concerns, delaying advancements in care and accessibility. However, recent years have seen the emergence of tracking technologies and wearable devices that enable long-term biomonitoring of key health biomarkers which promise to facilitate early disease diagnosis for women from all walks of life. These innovations value education and accessibility, which can break down barriers to health care access and management that has affected generations of women around the world. This review discusses emerging biomonitoring technologies for diagnosing and managing critical women's health conditions as defined by the World Health Organization, including breast and gynecological cancers, vaginal infections, fertility, pregnancy and post-menopausal osteoporosis. Additionally, we examine the current commercial landscape of women's health technologies, highlighting barriers to adoption, such as medical insurance access and socioeconomic status, as well as discuss opportunities for future innovation.

Indexed as

Biological MonitoringWomen's HealthBiomarkersBreast NeoplasmsFemaleHealth Services AccessibilityHumansPregnancyBiomarkers

Identifiers

PMID41006271
PMCPMC12475061

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.